Article info
Novel disease loci
Short report
Delineation of a new fibrillin-2-opathy with evidence for a role of FBN2 in the pathogenesis of carpal tunnel syndrome
- Correspondence to Dr Geert Mortier, Department of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650 Edegem, Belgium; geert.mortier{at}uantwerpen.be
Citation
Delineation of a new fibrillin-2-opathy with evidence for a role of FBN2 in the pathogenesis of carpal tunnel syndrome
Publication history
- Received April 14, 2020
- Revised July 8, 2020
- Accepted July 26, 2020
- First published September 8, 2020.
Online issue publication
October 22, 2021
Article Versions
- Previous version (8 September 2020).
- Previous version (5 October 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.